Publications by authors named "Marc A Riedl"

Claim this Profile
L
Long-Term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension.
Henriette Farkas, John Anderson, Laurence Bouillet, Teresa Caballero, Mauro Cancian, Marc A Riedl

J Allergy Clin Immunol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-S.
Jonathan A Bernstein, Emel Aygören-Pürsün, Mauro Cancian, Danny M Cohn, Timothy Craig, Marc A Riedl

Clin Transl Allergy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing a hereditary angioedema prevalence for the United States using a large administrative claims database.
Anthony J Castaldo, Karen E Wells, Subhan Khalid, Emaan Rashidi, Christine N Selva, Marc A Riedl

Ann Allergy Asthma Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donidalorsen Treatment of Hereditary Angioedema in Patients Previously on Long-Term Prophylaxis.
Marc A Riedl, Jonathan A Bernstein, Joshua S Jacobs, Timothy Craig, Aleena Banerji

J Allergy Clin Immunol Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes in the Phase III OASIS-HAE Study of Donidalorsen for Hereditary Angioedema.
Marc A Riedl, Aaron Yarlas, Laura Bordone, Sabrina Treadwell, Sophie Wang

Allergy· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitor.
Markus Magerl, Marc A Riedl, Luisa Karla Arruda, Andrea Bauer, Alejandro Berardi

J Allergy Clin Immunol Glob· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic testing for chronic spontaneous urticaria with or without angioedema: The do's, don't and maybe's.
Jonathan A Bernstein, Ignacio Ansotegui, Riccardo Asero, Aleena Banerji, Stephen Betschel, Marc A Riedl

World Allergy Organ J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting Obstacles.
Sandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, Paula J Busse, Timothy Craig, Marc A Riedl

J Allergy Clin Immunol Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lanadelumab for prevention of attacks of non-histaminergic normal C1 inhibitor angioedema: results from the randomized, double-blind CASPIAN Study and CASPIAN open-label extension.
Marc A Riedl, Petra Staubach, Henriette Farkas, Andrea Zanichelli, Hong Ren

Front Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary angioedema diagnosis: Reflecting on the past, envisioning the future.
Anete S Grumach, Marc A Riedl, Lei Cheng, Siddharth Jain, Daniel Nova Estepan

World Allergy Organ J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary angioedema: Patient health care experiences within underrepresented racial and ethnic groups in the United States.
Timothy Craig, Alan P Baptist, John Anderson, Rafael H Zaragoza-Urdaz, Autumn F Burnette, Marc A Riedl

Ann Allergy Asthma Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical burden, treatment, and disease control in patients with chronic spontaneous urticaria: Real-world evidence.
Marc A Riedl, Dhaval Patil, Jonathan Rodrigues, Merin Kuruvilla, Tara Raftery

Ann Allergy Asthma Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay between on-demand treatment trials for hereditary angioedema and treatment guidelines.
Danny M Cohn, Daniel F Soteres, Timothy J Craig, William R Lumry, Markus Magerl, Marc A Riedl

J Allergy Clin Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment.
Bruce L Zuraw, Konrad Bork, Laurence Bouillet, Sandra C Christiansen, Henriette Farkas, Marc A Riedl

Clin Rev Allergy Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a US quality of life instrument for hereditary angioedema due to C1 inhibitor deficiency.
Anthony J Castaldo, Nikolaj Siersbæk, Deborah Corcoran, Christine N Selva, Christian Jervelund, Marc A Riedl

Ann Allergy Asthma Immunol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of therapeutic options for hereditary angioedema.
Tukisa D Smith, Marc A Riedl

Ann Allergy Asthma Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus.
Avner Reshef, Thomas Buttgereit, Stephen D Betschel, Teresa Caballero, Henriette Farkas, Marc A Riedl

J Allergy Clin Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and Emerging Therapeutics in Hereditary Angioedema.
Toan Do, Marc A Riedl

Immunol Allergy Clin North Am· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Donidalorsen for Hereditary Angioedema.
Marc A Riedl, Raffi Tachdjian, William R Lumry, Timothy Craig, Gül Karakaya

N Engl J Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks.
Marc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, Fotis Psarros, Daniel F Soteres

N Engl J Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary angioedema outcomes in US patients switched from injectable long-term prophylactic medication to oral berotralstat.
Marc A Riedl, Daniel Soteres, J Wesley Sublett, Bhavisha Desai, Dianne Tomita

Ann Allergy Asthma Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Progress in Hepatic Targeting for Novel Prophylactic Therapies in Hereditary Angioedema.
Marc A Riedl, Laura Bordone, Alexey Revenko, Kenneth B Newman, Danny M Cohn

J Allergy Clin Immunol Pract· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema.
Remy S Petersen, Laura Bordone, Marc A Riedl, Raffi Tachdjian, Timothy J Craig

Allergy· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary angioedema in older adults: Understanding the patient perspective.
Alan P Baptist, George E Freigeh, Belinda Nelson, Laurie Carpenter, Nonie S Arora, Marc A Riedl

Ann Allergy Asthma Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat.
Danny M Cohn, Emel Aygören-Pürsün, Jonathan A Bernstein, Henriette Farkas, William R Lumry, Marc A Riedl

Clin Transl Allergy· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis